AzTrials
AzTrials

Pilonidal CystPILOLASNCT05513898

Treatment of Pilonidal Cyst With Holmium Laser

An observational study of Pilonidal Cyst, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Observational study on the treatment of pilonidal cyst with Holmium laser. Single-centre retrospective study of medical data from patients' medical records Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pilonidal Cyst
How many people
231 participants
Where
1 siteFrance
Study dates
1 Apr 2022to 31 Jan 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The patients participating in the study were operated on at the centre between AUGUST and NOVEMBER 2020. The study is based solely on a review of the medical records of these patients. No further evaluation is planned.

Who may be able to join

  • Patient aged 18 years or older, who has been informed of the research;
  • Patient with a pilonidal cyst treated with Holmium Laser during a scheduled procedure.

Who cannot join

  • Patient under legal protection, guardianship or curatorship;
  • Patient who has indicated his opposition to the use of his data.
  • Patient undergoing emergency surgery for an abscess

Trial locations and contacts

1 site in 1 country.

France1 site
  • Clinique de la Sauvegarde

    Lyon, 69009

Other trials in France

About this study

Observational study on the treatment of pilonidal cyst with Holmium laser. Single-centre retrospective study of medical data from patients' medical records

Read the detailed description

From the medical records of a series of patients treated for pilonidal cysts with Holmium laser:

  1. Primary objective: to assess the rate of healing at 1 month after Holmium laser treatment (healing being defined as no dressing)
  2. Secondary objectives: to assess the following:
  • Healing rate at last follow-up (1 month after surgery)
  • Recurrence rate at last follow-up (1 month after surgery)
  • Consumption of >1 level analgesics in the week and month following the procedure
  • Duration of nursing care
Conditions
Pilonidal Cyst
Medical subject headings
Pilonidal Sinus

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Healing rate

    explanatory analysis of the healing rate at Month 1

    Measured: Month 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Aug 2022
  2. Study start1 Apr 2022
  3. Primary completion31 Jan 2023
  4. Study completion31 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
231 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05513898
Sponsor's protocol ID
COS-RGDS-2020-06-028-
Acronym
PILOLAS
Status last verified
Jun 2024
First submitted
23 Jun 2022
Last updated
1 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pilonidal Cyst, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Healing rate (time frame: Month 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2024; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in